195940 — HK inno.N Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
KR₩1tn
Enterprise Value
KR₩2tn
Revenue
KR₩1tn

Annual income statement for HK inno.N, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	769,786	846,522	828,908	897,142	1,063,151
Cost of Revenue
Gross Profit	317,915	349,424	375,967	435,073	487,637
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	719,463	794,483	768,289	812,679	954,589
Operating Profit	50,323	52,039	60,619	84,463	108,562
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	27,785	37,818	45,166	71,735	91,323
Provision for Income Taxes
Net Income After Taxes	24,736	38,134	47,199	61,580	75,700
Net Income Before Extraordinary Items
Net Income	24,736	38,134	47,199	61,580	75,700
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	24,736	38,134	47,199	61,580	75,700
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	988	1,363	1,785	2,290	2,820
Dividends per Share